Results 51 to 60 of about 5,517,215 (329)

Concomitant infection with COVID-19 and Mycoplasma pneumoniae

Biomedical Journal, 2020
In late 2019, cases of atypical pneumonia caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were first reported in Wuhan, China. The disease was officially called coronavirus disease 2019 (COVID-19) and has been declared a pandemic disease by the World Health Organization (WHO).
Huang, Allen Chung-Cheng, Huang, Chung-Guei, Yang, Cheng-Ta, Hu, Han-Chung   +3 more
openaire   +3 more sources

Schistosoma mansoni: reinfections and concomitant immunity in mice: importance of perfusion time after challenge infection for evaluation of immunoprotection

Memorias do Instituto Oswaldo Cruz, 1995
The concomitant immunity in the presence of repeated infections (with 15 cercariae) was studied in mice sacrificed on the 20th day after each infection. The comparison of the averages of immature worms, recovered from mice submitted to reinfection, with ...
Paulo Marcos Z. Coelho, Rômulo T. Mello, Teresinha E. V. Pollom   +2 more
doaj   +1 more source

Etiological and epidemiological features of concomitant acute intestinal infections in children

Журнал инфектологии, 2020
Objective: to study the frequency, etiological, age, epidemiological features of combined acute intestinal infections in children.Materials and methods.
N. V. Gonchar, I. V. Razd`yakonova, N. V. Skripchenko, S. G. Grigor’ev   +3 more
doaj   +1 more source

Facial erysipelas associated with a concomitant staphylococcal infection.

Nishi Nihon Hifuka, 1988
13才女児にみられた溶連菌による顔面丹毒の1例を報告した。病巣部より黄色ブドウ球菌が検出され混合感染と考えられた。丹毒では文献的にも黄色ブドウ球菌の混合感染が少なからず観察されているので治療にはβ-ラクタマーゼ耐性の抗生物質を使用した方がよいと考える。
MUTO, Masahiko, NISHIMURA, Masayuki, KIMURA, Hideto   +2 more
openaire   +1 more source

Effect of artesunate-mefloquine plus praziquantel, mefloquine plus praziquantel, and praziquantel on S. haematobium and concomitant co-infections at the second treatment follow-up.

, 2014
Effect of artesunate-mefloquine plus praziquantel, mefloquine plus praziquantel, and praziquantel on S. haematobium and concomitant co-infections at the second treatment follow-up.
Kigbafori D. Silué (128980), Eliézer K. N'Goran (108853), Nicaise A. N'Guessan (195087), N'Chou Monsan (599780), Jennifer Keiser (39606), Jürg Utzinger (39609), Lukas K. Adiossan (599779)   +6 more
core   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine, Hallie Coltin, Sylvia Cheng, Lucie Lafay‐Cousin, Vanan Issai Magimairajan, Craig Erker, Stéphanie Vairy, Lynette Bowes, Adam Fleming, Donna Johnston, Sarah McKillop, Roona Sinha, Julie Bennett, Christina Coleman, Laura Wheaton, Shayna Zelcer, Samuele Renzi, Thai Hoa Tran   +17 more
wiley   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani, Rachel K. Peterson, Avani D. Rao, Laurie J. McKenzie, Ahmed Magdy Elmotayam, Leslie Chang, Michael Roth, Susan L. McGovern   +7 more
wiley   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk, Sebastian Michaelis, Michaela Döring, Thomas Eichholz, Ursula Holzer, Martin Ebinger, Tim Flaadt, Rupert Handgretinger, Peter Lang, Jan Frederic Weller, Markus Mezger   +10 more
wiley   +1 more source

BEHAVIORAL AND MEMORY CHANGES IN Mus musculus COINFECTED BY Toxocara canis AND Toxoplasma gondii

Revista do Instituto de Medicina Tropical de São Paulo, 2014
Several researchers have stated that parasites can alter the behavior of their hosts, in order to increase the transmission rate, principally when prey-predator relationships are a reliable way of infection transmission.
Flávia Motta Corrêa, Pedro Paulo Chieffi, Susana A. Zevallos Lescano, Sergio Vieira dos Santos   +3 more
doaj   +1 more source

Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis- related graft failure and disseminated bacillus Calmette-Guérin infection

Haematologica, 2020
Emapalumab, a fully human anti-IFNγ monoclonal antibody, has been approved in the US as second-line treatment of primary hemophagocytic lymphohistiocytosis (HLH) patients and has shown promise in patients with graft failure (GF) requiring a second ...
Francesca Tucci, Vera Gallo, Federica Barzaghi, Francesca Ferrua, Maddalena Migliavacca, Valeria Calbi, Matteo Doglio, Elena Sophia Fratini, Zeynep Karakas, Sukru Guner, Matilde Zambelli, Cristina Parisi, Raffaella Milani, Salvatore Gattillo, Benedetta Mazzi, Chiara Oltolini, Maurizio Barbera, Cristina Baldoli, Daniela Maria Cirillo, Veronica Asnaghi, Cristina De Min, Maria Pia Cicalese, Fabio Ciceri, Alessandro Aiuti, Maria Ester Bernardo   +24 more
doaj   +1 more source